Patients who identify themselves within the broad category of LGBTQ (lesbian, gay, bisexual, transgender, and queer or questioning) are an increasingly visible population. Research has consistently shown that LGBTQ-identified individuals suffer higher rates of depression, suicide, anxiety, smoking, substance abuse, and sexually transmitted infections (STIs) than the general population.
Read More
Most psychiatrists have not been specifically trained in treating transgender patients. This is a problem, because as society has become more accepting of sexual and gender diversity, more of your patients are likely to divulge to you their transgender identity.
Read More
Dr. Olson, you are a psychiatrist with a special interest in sexuality, but from a personal perspective, you also wrote a book about your own experience coming out as gay later in life.
Read More
Deep brain stimulation (DBS) has suddenly begun popping up in both the medical journals and the mainstream media as a potential treatment for treatment resistant depression.
Read More
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.
KarXT (Cobenfy) is the first antipsychotic that doesn’t block dopamine. We trace the origins of this new drug to a South Asian herb used for over 5,000 years, up to the three...